Bolt Biotherapeutics Names Sheila Gujrathi Chief Strategy Officer

PUBT · 2d ago
Bolt Biotherapeutics Names Sheila Gujrathi Chief Strategy Officer
  • Bolt Biotherapeutics named Sheila Gujrathi chief strategy officer and a board member following its acquisition of Prana Therapies.
  • Gujrathi is Prana's co-founder and former chief executive officer.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bolt Biotherapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610230908PRIMZONEFULLFEED9851994) on October 23, 2026, and is solely responsible for the information contained therein.